EyePoint, Inc. (EYPT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.58+0.22%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · EYPT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 2.4 | 31.4 | 31.4 | 43.3 | 41.4 | 36.9 | 34.4 | 20.4 | 20.4 | 3.0 | 7.5 | 1.6 | 26.6 | 3.5 | 2.1 | 3.5 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 7.5 | 1.6 | 26.6 | 3.5 | 2.1 | 3.5 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 311.5 | 221.0 | 221.0 | 132.9 | 49.6 | 28.5 | 17.4 | 15.4 | 15.4 | 16.2 | 14.9 | 14.4 | 12.1 | 9.6 | 7.0 | 7.0 |
| Operating Income | (369.2) | (243.4) | (243.4) | (145.9) | (99.6) | (55.3) | (37.3) | (47.9) | (47.9) | (26.3) | (18.6) | (21.8) | 6.4 | (13.5) | (12.0) | (25.2) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | 0.0 | 0.0 | 3.2 | 5.5 | 7.3 | 6.2 | 6.2 | 0.7 | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | 10.5 | 11.8 | 11.8 | 15.1 | (2.6) | (3.1) | (8.1) | (8.9) | (8.9) | — | — | — | 0.0 | 0.0 | 0.0 | 0.2 |
| EBT, Incl. Unusual Items | — | (231.7) | (231.7) | (130.8) | (102.3) | (58.4) | (45.4) | (56.8) | (56.8) | (53.2) | (18.5) | (21.7) | 6.4 | (13.5) | (12.0) | (25.0) |
| Income Tax Expense | — | 0.3 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.2) | 0.1 | (0.1) | (0.1) | (0.2) |
| Net Income | ||||||||||||||||
| Net Income | (358.6) | (232.0) | (232.0) | (130.9) | (102.3) | (58.4) | (45.4) | (56.8) | (56.8) | (53.2) | (18.5) | (21.5) | 6.3 | (13.4) | (11.9) | (24.8) |
| Per Share | ||||||||||||||||
| Basic EPS | (4,143.65) | (3.17) | (3.17) | (2.32) | (2.74) | (2.03) | — | — | — | — | (0.52) | (0.68) | 0.22 | — | — | (1.19) |
| Diluted EPS | (4,143.65) | (3.17) | (3.17) | (2.32) | (2.74) | (2.03) | — | — | — | — | (0.52) | (0.68) | 0.21 | — | — | (1.19) |
| Revenue per Share | 27.80 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.1 | 0.1 | 0.1 | 0.1 | 37.3 | 28.8 | — | — | — | — | 35.3 | 31.6 | 29.4 | — | — | 20.8 |
| Diluted Weighted Avg Shares | 0.1 | 0.1 | 0.1 | 0.1 | 37.3 | 28.8 | — | — | — | — | 35.3 | 31.6 | 30.6 | — | — | 20.8 |
| Supplemental | ||||||||||||||||
| EBITDA | (366.6) | (241.1) | (241.1) | (144.3) | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | (369.2) | (243.4) | (243.4) | (145.9) | (99.6) | (55.3) | (37.3) | (47.9) | (47.9) | (26.3) | (18.6) | (21.8) | 6.4 | (13.5) | (12.0) | (25.2) |
| Effective Tax Rate | — | -0.1% | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 1.5% | 1.0% | 1.0% | 0.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.